<DOC>
	<DOCNO>NCT01043887</DOCNO>
	<brief_summary>This study evaluate pharmacokinetics ridaforolimus include area concentration-time curve ( AUC [ 0-infinity ] ) maximum concentration ( Cmax ) administration single dose ridaforolimus patient moderate hepatic insufficiency healthy match control subject .</brief_summary>
	<brief_title>Ridaforolimus Patients With Hepatic Insufficiency ( MK-8669-046 )</brief_title>
	<detailed_description />
	<mesh_term>Hepatic Insufficiency</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Hepatic Patients : Female patient nonchild bear potential Apart hepatic insufficiency feature cirrhosis , patient otherwise good health Patient diagnosis chronic stable hepatic insufficiency feature cirrhosis Healthy Subjects : Female subject nonchildbearing potential Subject good health Hepatic Patients Healthy Subjects : Works night shift able avoid night shift work study Has history stroke , seizure major neurological disease Has history cancer Is unable refrain anticipates use prescription nonprescription drug study Consumes excessive amount alcohol caffeine Has major surgery , donate blood participate another investigational study past 4 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Healthy Volunteers</keyword>
	<keyword>Hepatic Insufficiency</keyword>
</DOC>